Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Witt, O.
Right arrow Articles by Pekrun, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Witt, O.
Right arrow Articles by Pekrun, A.
Related Collections
Right arrow Neoplasia
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 95 No. 7 (April 1), 2000: pp. 2391-2396

Butyrate-induced erythroid differentiation of human K562 leukemia cells involves inhibition of ERK and activation of p38 MAP kinase pathways

Olaf Witt, Katrin Sand, and Arnulf Pekrun

From the Children's Hospital, University of Göttingen, Göttingen, Germany.

Butyrate induces cytodifferentiation in many tumor cells of different origin, suggesting that an as yet unidentified common mechanism inherent to malignant cells is the target of butyrate action. This study determined the role of different mitogen-activated protein (MAP) kinase signal transduction pathways in butyrate-induced erythroid differentiation of K562 human leukemia cells. Using a panel of anti-ERK, JNK, and p38 phosphospecific antibodies, the study showed that phosphorylation of ERK and JNK is decreased following treatment of cells with butyrate, whereas phosphorylation of p38 is increased. In contrast, a K562 subline defective in butyrate-mediated induction of erythroid differentiation did not reveal these changes in phosphorylation patterns. Inhibition of ERK activity by UO126 induces erythroid differentiation and acts synergistically with butyrate on hemoglobin synthesis and inhibition of cell proliferation, whereas inhibition of p38 activity by SB203580 completely abolished induction of hemoglobin expression by butyrate. Taken together, our data suggest a model in which butyrate induces erythroid differentiation of K562 cells by inhibition of ERK and activation of p38 signal transduction pathways.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
Y.-C. Twu, C.-P. Chen, C.-Y. Hsieh, C.-H. Tzeng, C.-F. Sun, S.-H. Wang, M.-S. Chang, and L.-C. Yu
I branching formation in erythroid differentiation is regulated by transcription factor C/EBP{alpha}
Blood, December 15, 2007; 110(13): 4526 - 4534.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
W. Aerbajinai, J. Zhu, Z. Gao, K. Chin, and G. P. Rodgers
Thalidomide induces {gamma}-globin gene expression through increased reactive oxygen species mediated p38 MAPK signaling and histone H4 acetylation in adult erythropoiesis
Blood, October 15, 2007; 110(8): 2864 - 2871.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
D. Bugarski, A. Krstic, S. Mojsilovic, M. Vlaski, M. Petakov, G. Jovcic, N. Stojanovic, and P. Milenkovic
Signaling Pathways Implicated in Hematopoietic Progenitor Cell Proliferation and Differentiation
Experimental Biology and Medicine, January 1, 2007; 232(1): 156 - 163.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
J. Sangerman, M. S. Lee, X. Yao, E. Oteng, C.-H. Hsiao, W. Li, S. Zein, S. F. Ofori-Acquah, and B. S. Pace
Mechanism for fetal hemoglobin induction by histone deacetylase inhibitors involves {gamma}-globin activation by CREB1 and ATF-2
Blood, November 15, 2006; 108(10): 3590 - 3599.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
Y. Zhang, M. Liao, and M. L. Dufau
Phosphatidylinositol 3-Kinase/Protein Kinase C{zeta}-Induced Phosphorylation of Sp1 and p107 Repressor Release Have a Critical Role in Histone Deacetylase Inhibitor-Mediated Depression of Transcription of the Luteinizing Hormone Receptor Gene.
Mol. Cell. Biol., September 1, 2006; 26(18): 6748 - 6761.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. A. McDevitt, J. Xie, G. Shanmugasundaram, J. Griffith, A. Liu, C. McDonald, P. Thuma, V. R. Gordeuk, C. N. Metz, R. Mitchell, et al.
A critical role for the host mediator macrophage migration inhibitory factor in the pathogenesis of malarial anemia
J. Exp. Med., May 15, 2006; 203(5): 1185 - 1196.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X.-S. Zhang, Z.-H. Zhang, X. Jin, P. Wei, X.-Q. Hu, M. Chen, C.-L. Lu, Y.-H. Lue, Z.-Y. Hu, A. P. Sinha Hikim, et al.
Dedifferentiation of Adult Monkey Sertoli Cells through Activation of Extracellularly Regulated Kinase 1/2 Induced by Heat Treatment
Endocrinology, March 1, 2006; 147(3): 1237 - 1245.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
Y. Shima, T. Maeda, S. Aizawa, I. Tsuboi, D. Kobayashi, R. Kato, and I. Tamai
L-arginine import via cationic amino acid transporter CAT1 is essential for both differentiation and proliferation of erythrocytes
Blood, February 15, 2006; 107(4): 1352 - 1356.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
M. Bordin, F. D'Atri, L. Guillemot, and S. Citi
Histone Deacetylase Inhibitors Up-Regulate the Expression of Tight Junction Proteins
Mol. Cancer Res., December 1, 2004; 2(12): 692 - 701.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
K. Maki, H. Arai, K. Waga, K. Sasaki, F. Nakamura, Y. Imai, M. Kurokawa, H. Hirai, and K. Mitani
Leukemia-Related Transcription Factor TEL Is Negatively Regulated through Extracellular Signal-Regulated Kinase-Induced Phosphorylation
Mol. Cell. Biol., April 15, 2004; 24(8): 3227 - 3237.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
N. Gurvich, O. M. Tsygankova, J. L. Meinkoth, and P. S. Klein
Histone Deacetylase Is a Target of Valproic Acid-Mediated Cellular Differentiation
Cancer Res., February 1, 2004; 64(3): 1079 - 1086.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. Secchiero, E. Melloni, M. Heikinheimo, S. Mannisto, R. Di Pietro, A. Iacone, and G. Zauli
TRAIL regulates normal erythroid maturation through an ERK-dependent pathway
Blood, January 15, 2004; 103(2): 517 - 522.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
C. Yu, M. Rahmani, D. Conrad, M. Subler, P. Dent, and S. Grant
The proteasome inhibitor bortezomib interacts synergistically with histone deacetylase inhibitors to induce apoptosis in Bcr/Abl+ cells sensitive and resistant to STI571
Blood, November 15, 2003; 102(10): 3765 - 3774.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Boren, W.-N. P. Lee, S. Bassilian, J. J. Centelles, S. Lim, S. Ahmed, L. G. Boros, and M. Cascante
The Stable Isotope-based Dynamic Metabolic Profile of Butyrate-induced HT29 Cell Differentiation
J. Biol. Chem., August 1, 2003; 278(31): 28395 - 28402.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
L. C. Platanias
Map kinase signaling pathways and hematologic malignancies
Blood, June 15, 2003; 101(12): 4667 - 4679.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. Wong, J. McLaughlin, D. Cheng, and O. N. Witte
Cell context-specific effects of the BCR-ABL oncogene monitored in hematopoietic progenitors
Blood, May 15, 2003; 101(10): 4088 - 4097.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
X. Cao, G. Flock, C. Choi, D. M. Irwin, and D. J. Drucker
Aberrant Regulation of Human Intestinal Proglucagon Gene Expression in the NCI-H716 Cell Line
Endocrinology, May 1, 2003; 144(5): 2025 - 2033.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Yu, M. Rahmani, J. Almenara, M. Subler, G. Krystal, D. Conrad, L. Varticovski, P. Dent, and S. Grant
Histone Deacetylase Inhibitors Promote STI571-mediated Apoptosis in STI571-sensitive and -resistant Bcr/Abl+ Human Myeloid Leukemia Cells
Cancer Res., May 1, 2003; 63(9): 2118 - 2126.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
O. Witt, S. Monkemeyer, G. Ronndahl, B. Erdlenbruch, D. Reinhardt, K. Kanbach, and A. Pekrun
Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin
Blood, March 1, 2003; 101(5): 2001 - 2007.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
S. M. Jacobs-Helber, K.-h. Roh, D. Bailey, E. N. Dessypris, J. J. Ryan, J. Chen, A. Wickrema, D. L. Barber, P. Dent, and S. T. Sawyer
Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia
Blood, January 15, 2003; 101(2): 524 - 531.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
A. Puig-Kroger, M. Relloso, O. Fernandez-Capetillo, A. Zubiaga, A. Silva, C. Bernabeu, and A. L. Corbi
Extracellular signal-regulated protein kinase signaling pathway negatively regulates the phenotypic and functional maturation of monocyte-derived human dendritic cells
Blood, October 1, 2001; 98(7): 2175 - 2182.
[Abstract] [Full Text] [PDF]


Home page
Cell Growth Differ.Home page
J.-I. Park, H.-S. Choi, J.-S. Jeong, J.-Y. Han, and I.-H. Kim
Involvement of p38 Kinase in Hydroxyurea-induced Differentiation of K562 Cells
Cell Growth Differ., September 1, 2001; 12(9): 481 - 486.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2000 by American Society of Hematology         Online ISSN: 1528-0020